Newmark Group Inc NMRK Q1 2026 Earnings EPS Beat Drives Slight Stock Uptick Amid Uncertain Revenue Outlook FRHC Q1 2026 Earnings Strong EPS Performance Despite Market Headwinds XEL Q1 2026 Earnings Slight EPS Miss Amid Stable Operations InMed Pharmaceuticals Q3 2025 Earnings Net Loss Widens Amid Pipeline Focus Lyell Immunopharma Q1 2026 Earnings Narrower Loss Surprises Expectations Amid Clinical Progress IAUX Q1 2026 Earnings Narrower Loss Beats Expectations as Development Progress Continues